Valuation (91%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 4.96 | 19.57 |
PEG Ratio (TTM) | 12.27 | -3.06 |
P/S Ratio (TTM) | 0.41 | 2.00 |
P/B Ratio (TTM) | 0.31 | 4.16 |
P/FCF Ratio (TTM) | 4.25 | 10.54 |
Price to 5YR AVG Earnings Ratio | 0.00 | 22.62 |
Price to 5YR AVG FCF Ratio | 0.01 | -32.24 |
Profitability (25%) |
Company | Industry |
---|---|---|
ROA (TTM) | 2.52% | 3.02% |
ROE (TTM) | 6.12% | 11.41% |
Net Profit Margin (TTM) | 4.09% | 0.65% |
ROIC 5YR AVG | 7.16% | 9.06% |
Growth (70%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 114.36% | 66.87% | 33.73% |
Revenue | 0.01% | 2.04% | 2.40% |
Net Income | 120.64% | 32.24% | 13.69% |
Cash Flow | 13.49% | 12.43% | 10.99% |
Health (51%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.08 | 0.84 |
Quick Ratio (TTM) | 1.01 | 0.79 |
D/E Ratio (TTM) | 0.61 | 1.67 |
Interest Coverage (TTM) | 8.57 | 6.79 |
Piotroski F-Score | 5 | 6 |
Altman Z-Score | 1.06 | 1.09 |
LTL to 5YR AVG FCF | 11.15 | -9.15 |
Shares Outstanding Growth 5YR AVG | -9.61% | 0.32% |